Advanced Proteome Therapeutics Corporation
APCH.V
TSX
| Weiss Ratings | APCH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | APCH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | APCH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | APCH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | APCH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.01 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Jul 15, 2024 | |||
| 52-Week High Price (Date) | Jul 15, 2024 | |||
| Valuation | APCH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 143.67K | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.05 | |||
| Earnings Per Share Growth | -290.91% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -10.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -0.15 | |||
| Enterprise Value/EBIT | -0.15 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | APCH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 40.71M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | APCH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (604) 690-3797 | |||
| Address | 8337 Eastlake Drive Burnaby, BC V5A 4W2 | |||
| Website | www.advancedproteome.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | APCH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | APCH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -126.03% | |||
| Return on Equity | -- | |||
| Income Statement | APCH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -921.80K | |||
| EBIT (TTM) | -925.50K | |||
| Net Income (TTM) | -2.04M | |||
| Net Income Avl. to Common (TTM) | -2.04M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -194.99% | |||
| EPS Diluted (TTM) | -0.05 | |||
| EPS Diluted Growth (Q YOY) | -207.63% | |||
| Balance Sheet | APCH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 38.70K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 61.60K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -21.70K | |||
| Current Ratio (Q) | 0.729 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 62.80K | |||
| Total Current Liabilities (Q) | 84.50K | |||
| Total Debt (Q) | 30.80K | |||
| Total Liabilities (Q) | 84.50K | |||
| Total Common Equity (Q) | -21.70K | |||
| Cash Flow | APCH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 99.70K | |||
| Cash from Financing (TTM) | 112.30K | |||
| Net Change in Cash (TTM) | -722.90K | |||
| Levered Free Cash Flow (TTM) | -1.41M | |||
| Cash from Operations (TTM) | -934.90K | |||
